Abstract:Background: Vascular calcification significantly influences the onset and outcome of cardiovascular events, yet no effective treatment currently exists. Dysfunction of osteoclastic macrophages contributes to the formation of calcification. Our previous studies have shown that sonodynamic therapy (SDT) can rapidly reverse atherosclerotic plaques by targeting macrophages. This study aimed to investigate the effect of SDT on reducing early or mild vascular calcification by modulating the function of osteoclastic macrophages. Methods: Thirty-two patients with symptomatic femoropopliteal peripheral artery disease (PAD) were recruited to evaluate changes in vessel CT values and the target-to-background ratio (TBR) using positron emission tomography/computed tomography (PET/CT) 30 days post-SDT. An early calcification model was established in ApoE-/- mice, followed by SDT intervention. Frozen plaque sections from the mice were collected for mass spectrometry imaging (MSI)-based spatial metabolic analysis in situ. The NHGRI-EBI GWAS Catalog database and the human single-cell eQTL database (scQTLbase) were employed to analyze the causal relationship between key enzyme genes involved in phosphatidic acid (PA) synthesis in macrophages and vascular calcification using two-sample Mendelian randomization. To investigate cell ossification, calcification, and underlying mechanisms, RAW264.7 mouse macrophages were treated with a medium containing receptor activator of nuclear factor kappa-B ligand (RANKL), while mouse aortic vascular smooth muscle cells (MOVAS cells) were exposed to a calcification medium. Results: SDT significantly reduced the number of mildly calcified sites and the target-to-background ratio (TBR) of these sites in patients with femoropopliteal peripheral artery disease (PAD). In ApoE-/- mice, SDT alleviated early calcification of atherosclerotic plaques. MSI revealed that SDT altered the composition and distribution of lipid metabolites in atherosclerotic plaques, notably increasing the content of PA in the early calcified regions. Analysis of single-cell sequencing databases showed that key enzyme genes involved in PA synthesis—PLD1, PLD3, AGPAT4, and diacylglycerol kinase E (DGKE)—were enriched in macrophages of human coronary artery plaques. Mendelian randomization analysis indicated that DGKE negatively regulated coronary artery calcification. In vitro studies demonstrated that PA mediates SDT to promote M1 macrophage fusion and enhance carbonic anhydrase II (CA2) expression, thereby improving osteoclastic function and alleviating early calcification of MOVAS cells via the reactive oxygen species (ROS)-DGKE-PA pathway. In vivo, the CA2 inhibitor acetazolamide impaired the effects of SDT and exacerbated early calcification of atherosclerotic plaques in ApoE-/- mice. Conclusion: This study demonstrates that PA-mediated SDT promotes M1 macrophage fusion and CA2 expression, improving osteoclastic function and alleviating early calcification through the ROS-DGKE-PA pathway.

Sonodynamic effect of an anti-inflammatory agent--emodin on macrophages

The Sonodynamic Effect of Curcumin on THP-1 Cell-Derived Macrophages.

Effects of 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy on Macrophages

Effect of Danshen on TLR2-triggered inflammation in macrophages

Apoptosis of THP-1 Derived Macrophages Induced by Sonodynamic Therapy Using a New Sonosensitizer Hydroxyl Acetylated Curcumin.

Membrane-permeabilized sonodynamic therapy enhances drug delivery into macrophages

Sonodynamic therapy for the treatment of atherosclerosis

The efficacy and mechanism of apoptosis induction by hypericin-mediated sonodynamic therapy in THP-1 macrophages

Combination of Hydroxyl Acetylated Curcumin and Ultrasound Induces Macrophage Autophagy with Anti-Apoptotic and Anti-Lipid Aggregation Effects

Sonodynamic therapy in atherosclerosis by curcumin nanosuspensions: Preparation design, efficacy evaluation, and mechanisms analysis

Sonodynamic therapy: A potential treatment for atherosclerosis

Sonodynamic Therapy Promotes Efferocytosis via CD47 Down-Regulation in Advanced Atherosclerotic Plaque

Phosphatidic Acid Mediated Sonodynamic Therapy Facilitates M1 Macrophage Osteoclastic Function and Alleviates Early Vascular Calcification

Macrophage-targeted ultrasound nanobubbles for highly efficient sonodynamic therapy of atherosclerotic plaques by modulating M1-to-M2 polarization

Regulatory Effects Of Emodin On Nf-Kappa B Activation And Inflammatory Cytokine Expression In Raw 264.7 Macrophages

Regulatory effects of emodin on NF-κB activation and inflammatory cytokine expression in RAW 264.7 macrophages

Inhibition of VDAC1 prevents Ca²⁺-mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages.

Sonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell Apoptosis

Early modulation of macrophage ROS-PPARγ-NF-κB signalling by sonodynamic therapy attenuates neointimal hyperplasia in rabbits

Inhibition of VDAC1 prevents Ca 2+ -mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages

Thylakoid engineered M2 macrophage for sonodynamic effect promoted cell therapy of early atherosclerosis